首页> 外文期刊>Quarterly Journal of Medicine >The role of rifampicin in the management of cutaneous leishmaniasis
【24h】

The role of rifampicin in the management of cutaneous leishmaniasis

机译:利福平在皮肤利什曼病治疗中的作用

获取原文
获取原文并翻译 | 示例
       

摘要

We assessed the efficacy of rifampicin in the treat- ment of cutaneous leishmaniasis (oriental sore) using a double-blind placebo-controlled study. We studied 46 patients with cutaneous leishmani- asis, of whom 23 received rifampicin (group A) and another 23 received placebo (group B) for a period of 4 weeks. Each patient was assessed clinically for size of lesion, type of lesion, duration of lesion, number of lesions, and distribution of lesions, initially, and at the end of 1 week, 2 weeks and 4 weeks.
机译:我们通过一项双盲安慰剂对照研究评估了利福平在治疗皮肤利什曼病(东方疮)中的疗效。我们研究了46例皮肤利什曼病患者,其中23例接受利福平治疗(A组),另23例接受安慰剂治疗(B组),为期4周。最初以及在1周,2周和4周结束时,对每位患者进行临床评估,包括病变的大小,病变的类型,病变的持续时间,病变的数量和病变的分布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号